
JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
Of the eight analysts who have coverage on the Abbott India stock, six have a ‘buy’ rating, while one each have ‘hold’ and ‘sell’ ratings.

Of the eight analysts who have coverage on the Abbott India stock, six have a ‘buy’ rating, while one each have ‘hold’ and ‘sell’ ratings.

ASML lifts Q1 revenue and profit forecasts and raises 2026 sales target on strong AI chip demand, memory tools surge, while China sales fall amid…

Gucci’s revenue declined 8% during the first quarter of the calendar year, Kering SA stated on Tuesday. This is almost twice the decline estimated by…

Gold prices in India dip slightly as global cues turn risk on, silver eases after breakout, with bullion facing resistance ahead.

Paras Defence signs 10 year exclusive deal with US Bandak Aviation to support Northstar aerial refuelling systems for Indian Air Force, shares jump over 8%.

Even has Jefferies has cut its price target on five cement stocks in its latest note, it still sees an upside potential of up to…

Muthoot Finance seeks shareholder approval to amend its charter and enter insurance distribution as a corporate agent across life, general and health segments in India

Sumit Kishore, Executive Director at Axis Capital, expects power demand to pick up going forward, supported by a favourable base and improving economic activity. He…

Seven analysts have coverage on Pine Labs now, with three each having a “buy” and “hold” recommendation, while one has a “sell” rating. The consensus…

RBI consults banks on boosting stable deposits as savings shift to markets, loan growth outpaces deposits, lenders seek new products and flexible rates to manage…